Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 56, Issue 5, 2007, Pages 693-698

  Tokuyama, Yoshiharu ^a   Osawa, Haruhiko ^b   Ishizuka, Toshiharu ^a   Onuma, Hiroshi ^b   Matsui, Kana ^c   Egashira, Toru ^c   Makino, Hideichi ^b   Kanatsuka, Azuma ^a  

^a Chiba Central Medical Center   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BML   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LEPTIN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RESISTIN;

EID: 34147192492     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.019     Document Type: Article

References (37)

1. Kosaka K., Kuzuya T., Hagura R., et al. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 13 (1996) S109-S119
2. Kosaka K., Kuzuya T., Hagura R., et al. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabet Med 13 (1996) S120-S126
3. Hara K., Okada T., Tobe K., et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271 (2000) 212-216
4. Hara K., Tobe K., Okada T., et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45 (2002) 740-743
5. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 (2002) 536-540
6. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J Clin Invest 106 (2000) 473-481
7. Matsuzawa Y. Adipocytokines and metabolic syndrome. Semin Vasc Med 5 (2005) 34-39
8. Koerner A., Kratzsch J., and Kiess W. Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (2005) 525-546
9. Matsuzawa Y., Funahashi T., Kihara S., et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
10. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
11. Osawa H., Yamada K., Onuma H., et al. The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75 (2004) 678-686
12. Osawa H., Onuma H., Ochi M., et al. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 335 (2005) 596-602
13. McTernan P.G., Kusminski C.M., and Kumar S. Resistin. Curr Opin Lipidol 17 (2006) 170-175
14. Fujinami A., Obayashi H., Ohta K., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 339 (2004) 57-63
15. Azuma K., Katsukawa F., Oguchi S., et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11 (2003) 997-1001
16. Utzschneider K.M., Carr D.B., Tong J., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
17. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88 (2003) 4848-4856
18. Yamauchi T., Kamon J., Ito Y., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 (2003) 762-769
19. Bergman R.N., Ider Y.Z., Bowden C.R., et al. Quantitative estimation of insulin sensitivity. Am J Physiol 236 (1979) E667-E677
20. Pacini G., and Bergman R.N. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23 (1986) 113-122
21. Kanatsuka A., Makino H., Sakurada M., et al. First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate. Metabolism 37 (1988) 878-884
22. Tokuyama Y., Sakurai K., Yagui K., et al. Pathophysiologic phenotypes of Japanese subjects with varying degrees of glucose tolerance: using the combination of C-peptide secretion rate and minimal model analysis. Metabolism 50 (2001) 812-818
23. World Health Organization. Diabetes mellitus: report of a WHO study group. WHO technical report series no. 727, Geneva (Switzerland): World Health Organization. 1985.
24. Emoto M., Nishizawa Y., Maekawa K., et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22 (1999) 818-822
25. Yatagai T., Nagasaka S., Taniguchi A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 10 (2003) 1274-1278
26. Okumura T., Taniguchi A., Nagasaka S., et al. Relationship of regional adiposity to serum leptin level in nonobese Japanese type 2 diabetic male patients. Diabetes Metab 29 (2003) 15-18
27. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
28. Taniguchi A., Fukushima M., Ohya M., et al. Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism 55 (2006) 258-262
29. Rangwala S.M., Rich A.S., Rhoades B., et al. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53 (2004) 1937-1941
30. Kitagawa Y., Bujo H., Takahashi K., et al. Impaired glucose tolerance is accompanied by decreased insulin sensitivity in tissues of mice implanted with cells that overexpress resistin. Diabetologia 47 (2004) 1847-1853
31. Satoh H., Nguyen M.T., Miles P.D., et al. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114 (2004) 224-231
32. Sone H., Ito H., Ohashi Y., et al. Japan Diabetes Complication Study Group. Obesity and type 2 diabetes in Japanese patients. Lancet 85 (2003) 361
33. Defronzo R.A., Bonadonna R.C., and Ferranini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15 (1992) 318-368
34. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
35. Shetty G.K., Economides P.A., Horton E.S., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
36. McTernan P.G., Fisher F.M., Valsamakis G., et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 88 (2003) 6098-6106
37. Yki-Jarvinen H. Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia 33 (1990) 579-585